Background2008Ideal Medical Products becomes Ideal Medical Products Engineering2007Takeover of SCIENT'X by U.S. investment fund Healthpoint.I.M.P. quotation in stock exchange is suspended. 2005Increase from 73,58 to 94.19% of SCIENT'X participation in SURGIVIEW.2002A reinforcement of Ideal Medical Products skills in the fields of medical structure consultancy, strategy and organisation thanks to the acquisition of IRIS CONSEIL SANTE.2000The company further establishes its presence in Asia by opening the Malaysian office Ideal Medical Products SEA Sdn Bhd.Acquisition of 50% of the company G.P.F (Gaz Purs & Fluids). 1997The company is transferred onto the Second Stock Exchange Market.1995The company enters the Stock Exchange on the unofficial market. It is renamed Ideal Medical Products.It then furthers its development in Europe by opening the Greek office. SCIENT'X, a company specialised in the study, design and distribution of implantable prostheses made of titanium for orthopaedic surgery and neurosurgery, joins the group. 1992The company branches out thanks to the acquisition of CETI, a Belgian company that designs and markets imaging systems for laboratories.Well established in Eastern Europe and Russia, the company confirms its position by opening its own Russian office: Zao Ideal Products. 1990Olivier Carli becomes President of the company.Making use of French medicine's famous world reputation, he develops export sales of medical equipment essentially to Russia and Eastern Europe. 1987On the 13 January 1987, Ideal Products was founded, a company that designs, studies and implements medical projectsPrint this page |